Non Alcoholic Fatty Liver Disease (NAFLD) - Market Insights, Epidemiology and Market Forecast - 2025

Publisher Name :
Date: 28-Jul-2017
No. of pages: 70
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Non Alcoholic Fatty Liver Disease (NAFLD) - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Non Alcoholic Fatty Liver Disease (NAFLD) for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Non Alcoholic Fatty Liver Disease (NAFLD) . It enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of Non Alcoholic Fatty Liver Disease (NAFLD) for 7 major markets.

The market outlook also provides understanding of country specific revenue and share by analyzing performance of the current therapies and thorough potential uptake of new products. Additionally, the Report highlights the frontrunners, the drivers and barriers for the Non Alcoholic Fatty Liver Disease (NAFLD) market, as well as treatment algorithm, current treatments & advancements are included.The chapters including marketed products highlights the advantages and disadvantages associated with therapies associated with Non Alcoholic Fatty Liver Disease (NAFLD) , providing an in-depth analysis of emerging therapies which will create an impact through their launch.

According to DelveInsight, the forecasted patient population of Non Alcoholic Fatty Liver Disease (NAFLD) for the year 2025 will be XX, increasing at a CAGR of XX% from 2015 to 2025 and the Non Alcoholic Fatty Liver Disease (NAFLD) 7MM market size is estimated to be USD XX by 2025.The DelveInsight Report will help in enhanced understanding of the Non Alcoholic Fatty Liver Disease (NAFLD) market from inside out, with transparency into the calculated patient forecasting data and estimated market size.

Key Coverage

  • Understanding historical and forecasted epidemiological data for Non Alcoholic Fatty Liver Disease (NAFLD) covering 7MM from 2015-2025.

  • Segment level epidemiology and market split for Non Alcoholic Fatty Liver Disease (NAFLD) .

  • The thorough assessment of competitors, market, current trends & treatments along with upcoming treatments for Non Alcoholic Fatty Liver Disease (NAFLD) .

  • The Report also covers the market size for 7MM (United States, EU 5 (Germany, Spain, Italy, France and United Kingdom) and Japan) from 2015-2025 and detailed historical and forecasted Non Alcoholic Fatty Liver Disease (NAFLD) market trends.

  • Thorough market distribution based on market share for Non Alcoholic Fatty Liver Disease (NAFLD) .

Reasons to buy

  • The report will help in developing business strategies by understanding trends shaping and driving the Non Alcoholic Fatty Liver Disease (NAFLD) market.

  • To understand the future market competition in the Non Alcoholic Fatty Liver Disease (NAFLD) market and Insightful review of the key market drivers and barriers.

  • Organize sales and marketing efforts by identifying the best opportunities for Non Alcoholic Fatty Liver Disease (NAFLD) in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.

  • Identification of strong upcoming players in market will help in devising strategies that will help in getting ahead of competitors.

Non Alcoholic Fatty Liver Disease (NAFLD) - Market Insights, Epidemiology and Market Forecast - 2025

Table of Contents

1. Report Introduction

2. Non Alcoholic Fatty Liver Disease (NAFLD) Market Overview at a Glance
2.1. Total Market Share Distribution of Non Alcoholic Fatty Liver Disease (NAFLD) for 7 MM in 2016
2.2. Total Market Share Distribution of Non Alcoholic Fatty Liver Disease (NAFLD) for 7 MM in 2025

3. Non Alcoholic Fatty Liver Disease (NAFLD)
3.1.1. Overview
3.1.2. Symptoms
3.1.3. Pathophysiology
3.1.4. Staging
3.1.5. Diagnosis
3.1.6. Treatment

4. Epidemiology and Patient Population
4.1.1. United States
4.1.1.1. Diagnosed Cases of Non Alcoholic Fatty Liver Disease (NAFLD) in United States
4.1.2. Germany
4.1.2.1. Diagnosed Cases of Non Alcoholic Fatty Liver Disease (NAFLD) in Germany
4.1.3. France
4.1.3.1. Diagnosed Cases of Non Alcoholic Fatty Liver Disease (NAFLD) in France
4.1.4. Italy
4.1.4.1. Diagnosed Cases of Non Alcoholic Fatty Liver Disease (NAFLD) in Italy
4.1.5. Spain
4.1.5.1. Diagnosed Cases of Non Alcoholic Fatty Liver Disease (NAFLD) in Spain
4.1.6. United Kingdom
4.1.6.1. Diagnosed Cases of Non Alcoholic Fatty Liver Disease (NAFLD) in United Kingdom

5. Treatment Algorithm
5.1.1. Treatment Guidelines/Practices

6. Marketed Drugs for Non Alcoholic Fatty Liver Disease (NAFLD)
6.1. Drug 1: Company A
6.1.1. Drug Description
6.1.2. Mechanism of Action
6.1.3. Regulatory Milestones
6.1.4. Advantages & Disadvantages
6.1.5. Safety and Efficacy
6.1.6. Product Profile
6.1.7. Patent Status
6.2. Drug 2: Company B
6.2.1. Drug Description
6.2.2. Mechanism of Action
6.2.3. Regulatory Milestones
6.2.4. Advantages & Disadvantages
6.2.5. Safety and Efficacy
6.2.6. Product Profile
6.2.7. Patent Status

7. Emerging Therapies
7.1. Drug 3: Company C
7.1.1. Description
7.1.2. Regulatory Milestones
7.1.3. Advantages & Disadvantages
7.1.4. Product Profile
7.1.5. Launch Date
7.1.6. Clinical Development
7.1.7. Clinical Pipeline Activity
7.1.8. Ongoing Trials Information
7.1.9. Clinical Trial by Phase
7.2. Drug 4: Company B
7.2.1. Description
7.2.2. Regulatory Milestones
7.2.3. Advantages & Disadvantages
7.2.4. Product Profile
7.2.5. Launch Date
7.2.6. Clinical Development
7.2.7. Clinical Pipeline Activity
7.2.8. Ongoing Trials Information
7.2.9. Clinical Trial by Phase

8. Overview of Total Non Alcoholic Fatty Liver Disease (NAFLD) Market (2016 & 2025)

9. Non Alcoholic Fatty Liver Disease (NAFLD) : Country-Wise Market Analysis
9.1. United States
9.1.1. Historical Market Size (2015-2016)
9.1.2. Forecasted Market Size (2017-2025)
9.2. Germany Market Size
9.2.1. Historical Market Size (2015-2016)
9.2.2. Forecasted Market Size (2017-2025)
9.3. France Market Size
9.3.1. Historical Market Size (2015-2016)
9.3.2. Forecasted Market Size (2017-2025)
9.4. United Kingdom Market Size
9.4.1. Historical Market Size (2015-2016)
9.4.2. Forecasted Market Size (2017-2025)
9.5. Spain Market Size
9.5.1. Historical Market Size (2015-2016)
9.5.2. Forecasted Market Size (2017-2025)
9.6. Italy Market Size
9.6.1. Historical Market Size (2015-2016)
9.6.2. Forecasted Market Size (2017-2025)
9.7. Japan Market Size
9.7.1. Historical Market Size (2015-2016)
9.7.2. Forecasted Market Size (2017-2025)

10. Market Drivers

11. Market Restraints

12. Appendix

13. Report Methodology

14. Consulting Services

15. Disclaimer

16. About DelveInsight

List of Tables

Table 1: Diagnosed Cases Non Alcoholic Fatty Liver Disease (NAFLD) in United States (2015-2025)
Table 2: Diagnosed Cases Non Alcoholic Fatty Liver Disease (NAFLD) in Germany (2015-2025)
Table 3: Diagnosed Cases Non Alcoholic Fatty Liver Disease (NAFLD) in France (2015-2025)
Table 4: Diagnosed Cases Non Alcoholic Fatty Liver Disease (NAFLD) in United Kingdom (2015-2025)
Table 5: Diagnosed Cases Non Alcoholic Fatty Liver Disease (NAFLD) in Spain (2015-2025)
Table 6: Diagnosed Cases Non Alcoholic Fatty Liver Disease (NAFLD) in Italy (2015-2025)
Table 7: Diagnosed Cases Non Alcoholic Fatty Liver Disease (NAFLD) in Japan (2015-2025)
Table 8: List of Marketed Drugs for Non Alcoholic Fatty Liver Disease (NAFLD)
Table 9: List of Pipeline Phase III Drugs for Non Alcoholic Fatty Liver Disease (NAFLD)
Table 10: Drug 1, Clinical Trials by Zone, 2017
Table 11: Clinical Trials by Trial status, 2017
Table 12: Drug 2, Clinical Trials by Zone, 2017
Table 13: Clinical Trials by Trial status, 2017
Table 14: Drug 3, Clinical Trials by Zone, 2017
Table 15: Clinical Trials by Trial status, 2017
Table 16: United States Market Size of Non Alcoholic Fatty Liver Disease (NAFLD) in USD, Million (2015-2025)
Table 17: Germany Market Size of Non Alcoholic Fatty Liver Disease (NAFLD) in USD, Million (2015-2025)
Table 18: France Market Size of Non Alcoholic Fatty Liver Disease (NAFLD) in USD, Million (2015-2025)
Table 19: United Kingdom Market Size of Non Alcoholic Fatty Liver Disease (NAFLD) in USD, Million (2015-2025)
Table 20: Spain Market Size of Non Alcoholic Fatty Liver Disease (NAFLD) in USD, Million (2015-2025)
Table 21: Italy Market Size of Non Alcoholic Fatty Liver Disease (NAFLD) in USD, Million (2015-2025)
Table 22: Japan Market Size of Non Alcoholic Fatty Liver Disease (NAFLD) in USD, Million (2015-2025)

List of Figures

Figure 1: Diagnosed Cases Non Alcoholic Fatty Liver Disease (NAFLD) in United States (2015-2025)
Figure 2: Diagnosed Cases Non Alcoholic Fatty Liver Disease (NAFLD) in Germany (2015-2025)
Figure 3: Diagnosed Cases Non Alcoholic Fatty Liver Disease (NAFLD) in France (2015-2025)
Figure 4: Diagnosed Cases Non Alcoholic Fatty Liver Disease (NAFLD) in United Kingdom (2015-2025)
Figure 5: Diagnosed Cases Non Alcoholic Fatty Liver Disease (NAFLD) in Spain (2015-2025)
Figure 6: Diagnosed Cases Non Alcoholic Fatty Liver Disease (NAFLD) in Italy (2015-2025)
Figure 7: Diagnosed Cases Non Alcoholic Fatty Liver Disease (NAFLD) in Japan (2015-2025)
Figure 8: List of Marketed Drugs for Non Alcoholic Fatty Liver Disease (NAFLD)
Figure 9: List of Pipeline Phase III Drugs for Non Alcoholic Fatty Liver Disease (NAFLD)
Figure 10: Drug 1, Clinical Trials by Zone (%), 2017
Figure 11: Clinical Trials by Trial status, 2017
Figure 12: Drug 2, Clinical Trials by Zone (%), 2017
Figure 13: Clinical Trials by Trial status, 2017
Figure 14: Drug 3, Clinical Trials by Zone (%), 2017
Figure 15: Clinical Trials by Trial status, 2017
Figure 16: United States Market Size of Non Alcoholic Fatty Liver Disease (NAFLD) in USD, Million (2015-2025)
Figure 17: Germany Market Size of Non Alcoholic Fatty Liver Disease (NAFLD) in USD, Million (2015-2025)
Figure 18: France Market Size of Non Alcoholic Fatty Liver Disease (NAFLD) in USD, Million (2015-2025)
Figure 19: United Kingdom Market Size of Non Alcoholic Fatty Liver Disease (NAFLD) in USD, Million (2015-2025)
Figure 20: Spain Market Size of Non Alcoholic Fatty Liver Disease (NAFLD) in USD, Million (2015-2025)
Figure 21: Italy Market Size of Non Alcoholic Fatty Liver Disease (NAFLD) in USD, Million (2015-2025)
Figure 22: Japan Market Size of Non Alcoholic Fatty Liver Disease (NAFLD) in USD, Million (2015-2025)
  • United States Virus Like Particles Market Report 2017
    Published: 12-Oct-2017        Price: US 3800 Onwards        Pages: 107
    In this report, the United States Virus Like Particles market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rat......
  • Global Virus Like Particles Sales Market Report 2017
    Published: 10-Oct-2017        Price: US 4000 Onwards        Pages: 118
    In this report, the global Virus Like Particles market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Virus Like Particles for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Ja......
  • Heavy Metal Poisoning - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 40
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Heavy Metal Poisoning - Pipeline Review, H2 2017, provides an overview of the Heavy Metal Poisoning (Toxicology) pipeline landscape.Heavy metal poisoning is the accumulation of heavy metals, in toxic amounts, in the soft tissues of the body. Sources of toxicity can include environmental, water supply, industrial and hobbies. Symptoms include headaches, drowsiness, confusion, seizures, nausea, vomiting, abdomin......
  • Radiation Injury - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 46
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Radiation Injury - Pipeline Review, H2 2017, provides an overview of the Radiation Injury (Toxicology) pipeline landscape.Radiation injury is damage to tissues caused by exposure to ionizing radiation. Symptoms depend on whether radiation exposure involves the whole body or is limited to a small portion of the body. At high doses, whole-body exposure causes acute radiation illness, and partial-body exposure ca......
  • Low Back Pain - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 98
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Low Back Pain - Pipeline Review, H2 2017, provides an overview of the Low Back Pain (Central Nervous System) pipeline landscape.Low back pain can happen anywhere below the ribs and above the legs. Causes of low back pain include overuse, strain, or injury, aging, arthritis, illness and cancer involving the spine. Symptoms include tingling or burning sensation, a dull achy feeling, or sharp pain and weakness in......
  • Binge Eating Disorder - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 62
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Binge Eating Disorder - Pipeline Review, H2 2017, provides an overview of the Binge Eating Disorder (Central Nervous System) pipeline landscape.Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological factors, long-term dieting and psychological issues increase your risk. Signs ......
  • Global Microbiome Therapeutics Market Research Report 2017
    Published: 10-Oct-2017        Price: US 2900 Onwards        Pages: 127
    In this report, the global Microbiome Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Microbiome Therapeutics in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - Ch......
  • Global Sexual Dysfunction Partnering 2010 to 2017
    Published: 01-Oct-2017        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Sexual Dysfunction Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides ......
  • Global Musculoskeletal Partnering 2010-2017: Deal trends, players and financials
    Published: 01-Oct-2017        Price: US 2995 Onwards        Pages: 1000
    "Delivery of this report will take 1-3 days after purchase." Global Musculoskeletal Partnering 2010 to 2017 provides the full collection of Musculoskeletal disease deals signed between the world's pharmaceutical and biotechnology companies since 2010. Trends in Musculoskeletal partnering deals Financial deal terms for headline, upfront and royalty by stage of development Musculoskeletal partnering agreement structure Musculoskel......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs